Today Eli Lilly and Co. announced the FDA approval of Cymbalta (duloxetine HCI) for the management of fibromyalgia. Cymbalta is the first serotonin-norepinephrine reuptake inhibitor with proven efficacy for reducing pain in patients with fibromyalgia. This makes Cymbalta the second medication ever to be approved for fibromyalgia, following Lyrica’s approval in June 2007.
This is exciting news for fibromyalgia patients. No single medication or treatment is right for everyone, so the...
